Clinical Trials Browser

Phase 1/2 × NIH × Liver Neoplasms × Clear all

Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT01306058 2019-01-23

Sorafenib and TRC105 in Hepatocellular Cancer

Phase 1/2 Completed

27 enrolled 32 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Liver Neoplasms, Experimental, Adenoma, Liver Cell

NCT00021047 2012-03-08

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Phase 1/2 Completed

CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Esthesioneuroblastoma, Olfactory

Clinical Trials

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Sorafenib and TRC105 in Hepatocellular Cancer

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor